Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

Kristina S Chen,1 Jipan Xie,2 Wenxi Tang,3 Jing Zhao,4 Palle B Jeppesen,5 James E Signorovitch4 1Outcomes Research and Epidemiology, Shire Human Genetic Therapies, Inc., Cambridge, MA, USA; 2Analysis Group, Inc., Los Angeles, CA, USA; 3Analysis Group, Inc., New York, NY, USA; 4Analysis Group, Inc.,...

Full description

Bibliographic Details
Main Authors: Chen KS, Xie J, Tang W, Zhao J, Jeppesen PB, Signorovitch JE
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Therapeutics and Clinical Risk Management
Subjects:
short bowel syndrome
intestinal failure
teduglutide
subpopulation
Online Access:https://www.dovepress.com/identifying-a-subpopulation-with-higher-likelihoods-of-early-response--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/identifying-a-subpopulation-with-higher-likelihoods-of-early-response--peer-reviewed-article-TCRM

Similar Items